C R Brohet
- LDL-C goal attainment with the addition of ezetimibe to ongoing simvastatin treatment in coronary heart disease patients with hypercholesterolemiaC Brohet
Saint Luc Hospital Catholic University of Louvain, Brussels, Belgium
Curr Med Res Opin 21:571-8. 2005..To evaluate the addition of ezetimibe or placebo to on-going simvastatin treatment on attaining the LDL-C treatment target of </= 2.60 mmol/L (100 mg/dL) in coronary heart disease (CHD) patients with hypercholesterolemia...
- What's new in cardiovascular prevention?C R Brohet
Cliniques Universitaires Saint Luc, Service de Pathologie cardio vasculaire, Avenue Hippocrate 10, 1200 Bruxelles, Belgium
Acta Clin Belg 62:317-22. 2007..Recent studies on antioxydant vitamins, homocysteine-lowering vitamins and HDL-Cholesterol raising drugs are also being discussed...
- Effects of spironolactone-altizide on left ventricular hypertrophyS Degre
, , Brussels, Belgium
Acta Cardiol 53:261-7. 1998....
- Lessons from ONTARGETV Berlaimont
Medical Department, Boehringer Ingelheim, Brussels, Belgium
Acta Clin Belg 63:142-51. 2008..ONTARGET is a landmark study, performed according to the highest statistical and clinical standards, providing compelling evidence and clear answers to two important clinical questions...